| Howard F Marks Jr, MD | |
|
1912 Tradd Ct, Wilmington, NC 28401-6637 | |
| (910) 251-3766 | |
| (910) 251-3760 |
| Full Name | Howard F Marks Jr |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 43 Years |
| Location | 1912 Tradd Ct, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063437168 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 32138 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nhrmc Home Care | Rocky point, NC | Home health agency |
| New Hanover Regional Medical Center | Wilmington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Health Medical Group Coastal Region Llc | 2860809936 | 412 |
News Archive
The draw is huge: Play video games and get smarter. For the past decade, various groups have claimed that their cognitive training programs do everything from staving off neurodegenerative disease to enhancing education and improving daily functioning. Absent from many of these claims has been neuroscientific evidence. Cognitive neuroscientists are now rigorously testing the potential benefits of such "brain training" tools.
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing investor, to sell 13,636,364 shares of its common stock and warrants, expiring on December 31, 2015, to purchase an aggregate of approximately 4,772,728 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $9 million.
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.
COVID-19 has created new problems for pregnant women in the United States, a group that already faced the highest maternal mortality rate in the developed world even before the pandemic.
› Verified 2 days ago
| Entity Name | Novant Health New Hanover Regional Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750978839 PECOS PAC ID: 7113330168 Enrollment ID: O20210112000621 |
News Archive
The draw is huge: Play video games and get smarter. For the past decade, various groups have claimed that their cognitive training programs do everything from staving off neurodegenerative disease to enhancing education and improving daily functioning. Absent from many of these claims has been neuroscientific evidence. Cognitive neuroscientists are now rigorously testing the potential benefits of such "brain training" tools.
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing investor, to sell 13,636,364 shares of its common stock and warrants, expiring on December 31, 2015, to purchase an aggregate of approximately 4,772,728 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $9 million.
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.
COVID-19 has created new problems for pregnant women in the United States, a group that already faced the highest maternal mortality rate in the developed world even before the pandemic.
› Verified 2 days ago
| Entity Name | Novant Health Medical Group Coastal Region Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649865791 PECOS PAC ID: 2860809936 Enrollment ID: O20210408000285 |
News Archive
The draw is huge: Play video games and get smarter. For the past decade, various groups have claimed that their cognitive training programs do everything from staving off neurodegenerative disease to enhancing education and improving daily functioning. Absent from many of these claims has been neuroscientific evidence. Cognitive neuroscientists are now rigorously testing the potential benefits of such "brain training" tools.
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing investor, to sell 13,636,364 shares of its common stock and warrants, expiring on December 31, 2015, to purchase an aggregate of approximately 4,772,728 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $9 million.
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.
COVID-19 has created new problems for pregnant women in the United States, a group that already faced the highest maternal mortality rate in the developed world even before the pandemic.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Howard F Marks Jr, MD 1912 Tradd Ct, Wilmington, NC 28401-6637 Ph: (910) 251-3766 | Howard F Marks Jr, MD 1912 Tradd Ct, Wilmington, NC 28401-6637 Ph: (910) 251-3766 |
News Archive
The draw is huge: Play video games and get smarter. For the past decade, various groups have claimed that their cognitive training programs do everything from staving off neurodegenerative disease to enhancing education and improving daily functioning. Absent from many of these claims has been neuroscientific evidence. Cognitive neuroscientists are now rigorously testing the potential benefits of such "brain training" tools.
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing investor, to sell 13,636,364 shares of its common stock and warrants, expiring on December 31, 2015, to purchase an aggregate of approximately 4,772,728 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $9 million.
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.
COVID-19 has created new problems for pregnant women in the United States, a group that already faced the highest maternal mortality rate in the developed world even before the pandemic.
› Verified 2 days ago
Ivan David, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 1912 Tradd Court, Wilmington, NC 28401 Phone: 910-251-3766 Fax: 910-251-3760 | |
Peter Kane, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1912 Tradd Ct, Wilmington, NC 28401 Phone: 910-251-3766 Fax: 910-251-3760 |